Skip to main content

Advertisement

SpringerLink
Log in

Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Transarterial chemoembolization using microspheres is a new treatment option for patients with hepatocellular carcinoma. Objective To assess the effectiveness of this technique, in terms of tumor response and overall survival rates, and to assess the procedure’s safety. Setting A General University Hospital in Spain. Methods Single-center retrospective observational study. The cohort included all patients treated between October 2006 and April 2010. Effectiveness was determined by the tumor response rate (using modified RECIST and EASL criteria) and overall survival. Safety was assessed according to the Common Terminology Criteria for Adverse Events. Main outcome measure Tumor response rate, overall survival and safety of transarterial chemoembolization in patients with hepatocelular carcinoma. Results 53 patients were treated (81.1 % men, median age 65). Baseline characteristics 98.1 % had cirrhosis, 75.5 % Child-Pugh Class A, 71.7 % Okuda I, and 94.3 % were ECOG 0. 43.4 % were waiting for a liver transplant and 56.6 % were given the treatment as a palliative measure. Eighty-one procedures were carried out, with a median of 1 per patient [1–5]. Four weeks after treatment, the objective response rate was 87.5 % and the complete response rate was 62.5 %. Median survival was 735 days (CI 95 %: 351.9–1118.1). The 1, 2 and 3-year overall survival rates were 65.4, 50.9 and 42.5 %, respectively. 71.7 % of patients experienced post-embolization syndrome, with grade 1 abdominal pain as the most frequent symptom (37.7 %). Conclusion This study provides new evidence of the safety and effectiveness of transarterial chemoembolization using doxorubicin-loaded microspheres for the treatment of hepatocellular carcinoma in patients who are not eligible for other treatments, or as a bridging treatment in patients on the liver transplant waiting list.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010;15(Suppl 4):5–13.

    Article  PubMed  Google Scholar 

  2. GLOBOCAN 2008, International Agency for Research of Cancer. Updated Jan 2009. Last cited 06-2013. Available from: http://globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900.

  3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  PubMed  CAS  Google Scholar 

  4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–36.

    Article  PubMed  Google Scholar 

  5. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19(3):271–85.

    Article  PubMed  CAS  Google Scholar 

  6. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155(4):323–31.

    Article  PubMed  CAS  Google Scholar 

  7. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35–50.

    Article  PubMed  Google Scholar 

  8. Vilana R, Forner A, Garcia A, Ayuso C, Bru C. Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies. Radiologia. 2011;53(2):156–8.

    Article  PubMed  CAS  Google Scholar 

  9. NCCN Clinical Practice Guidelines in Oncology. Updated Oct 2011. Last cited 06-2013. Available from: http://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.

  10. Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology. 2011;53(3):1020–2.

    Article  PubMed  Google Scholar 

  11. Eastern Cooperative Oncology Group. Updated Jul 2006. Last cited 06-2013. Available from: http://ecog.dfci.harvard.edu/general/perf_stat.html.

  12. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421–30.

    Article  PubMed  CAS  Google Scholar 

  13. Robles R, Marin C, Lopez-Conesa A, Capel A, Parrilla P. Chemical embolisation before laparoscopic hepatic resection in early hepatocellular carcinoma in cirrhotic patients. Cir Esp. 2009;86(5):303–7.

    Article  PubMed  Google Scholar 

  14. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60.

    Article  PubMed  CAS  Google Scholar 

  15. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9.

    Article  PubMed  Google Scholar 

  16. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46(3):474–81.

    Article  PubMed  CAS  Google Scholar 

  17. Poon RT, Tso WK, Pang RW, Ng KK, Woo R, Tai KS, et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol. 2007;5(9):1100–8.

    Article  PubMed  CAS  Google Scholar 

  18. Wigmore SJ, Redhead DN, Thomson BN, Currie EJ, Parks RW, Madhavan KK, et al. Postchemoembolisation syndrome–tumour necrosis or hepatocyte injury? Br J Cancer. 2003;89(8):1423–7.

    Article  PubMed  CAS  Google Scholar 

  19. Patel NH, Hahn D, Rapp S, Bergan K, Coldwell DM. Hepatic artery embolization: factors predisposing to postembolization pain and nausea. J Vasc Interv Radiol. 2000;11(4):453–60.

    Article  PubMed  CAS  Google Scholar 

  20. Malagari K, Chatzimichael K, Alexopoulou E, Kelekis A, Hall B, Dourakis S, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol. 2008;31(2):269–80.

    Article  PubMed  Google Scholar 

  21. Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study. HPB (Oxford). 2010;12(3):174–80.

    Article  PubMed  Google Scholar 

  22. Common Terminology Criteria for Adverse Events (CTCAE) v4.02. Updated May 2009. Last cited 06-2013. Available from: http://www.acrin.org/.

  23. Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52.

    Article  PubMed  Google Scholar 

  24. Malagari K, Pomoni M, Spyridopoulos TN, Moschouris H, Kelekis A, Dourakis S, et al. Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) Patients. Cardiovasc Intervent Radiol. 2011;34(4):774–85.

    Article  PubMed  Google Scholar 

  25. Forner A, Ayuso C, Isabel RM, Sastre J, Robles R, Sangro B, et al. Diagnosis and treatment of hepatocellular carcinoma. Med Clin (Barc). 2009;132(7):272–87.

    Article  PubMed  Google Scholar 

  26. Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2009;15(11):1301–14.

    Article  PubMed  Google Scholar 

  27. Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, et al. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl. 2007;13(5):665–71.

    Article  PubMed  Google Scholar 

  28. Jelic S, Sotiropoulos GC. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v59–64.

    Article  PubMed  Google Scholar 

  29. Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, et al. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009;15(6):526–32.

    Article  PubMed  CAS  Google Scholar 

  30. Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, Ryan S, et al. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging. 2008;33(5):512–9.

    Article  PubMed  Google Scholar 

  31. Ferrer P, la Parra C, Esteban E, Vano M, Forment M, Vera A, et al. Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma. Radiologia. 2011;53(3):246–53.

    Article  Google Scholar 

  32. Burrel M, Reig M, Forner A, Barrufet M, Lope CR, Tremosini S, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol. 2012;56(6):1330–5.

    Article  PubMed  Google Scholar 

  33. Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, et al. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization. Onkologie. 2010;33(1–2):31–7.

    PubMed  CAS  Google Scholar 

Download references

Funding

None.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Pharmacy Department, Fresenius Medical Care Services Murcia SL, C/Valle de Ordesa, 45, 30740, San Pedro del Pinatar, Murcia, Spain

    María Muros-Ortega

  2. Pharmacy Department, Virgen de la Arrixaca Hospital, Murcia, Spain

    Mª Sacramento Díaz-Carrasco

  3. Radiology Department, Virgen de la Arrixaca Hospital, Murcia, Spain

    Antonio Capel

  4. Pharmacy Department, Virgen de las Nieves Hospital, Granada, Spain

    Miguel Ángel Calleja

  5. Faculty of Pharmacy, Department of Physical Chemistry, University of Granada, Granada, Spain

    Fernando Martínez

Authors
  1. María Muros-Ortega
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mª Sacramento Díaz-Carrasco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Capel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miguel Ángel Calleja
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fernando Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to María Muros-Ortega.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muros-Ortega, M., Díaz-Carrasco, M.S., Capel, A. et al. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma. Int J Clin Pharm 35, 1105–1112 (2013). https://doi.org/10.1007/s11096-013-9831-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9831-7

Keywords

Search

Navigation